Correlation between arsenic methylation metabolism and skin and liver damage in patients with coal-burning arsenism
-
摘要:
目的 分析燃煤型砷中毒人群尿砷甲基化代谢水平,探讨其与砷中毒皮肤和肝脏损害的关系。 方法 以贵州省黔西南州雨樟燃煤污染型砷中毒病区为调查点,筛选符合《地方性砷中毒诊断》(WS/T 211 — 2015)标准的202例燃煤型砷中毒患者,根据皮肤损伤诊断标准分为皮肤损害轻度组(48例)、中度组(70例)和重度组(84例);选择距该病区12 km外无燃用高砷煤史、且生活习惯相近的56名健康居民作为对照组。以肝功能指标白蛋白(ALB)、白蛋白与球蛋白比值(A/G)反映砷中毒人群肝损害情况。采用高效液相色谱 – 电感耦合等离子体质谱(HPLC-ICP-MS)检测调查对象尿中三价砷(As3+)、五价砷(As5+)、一甲基砷(MMA)和二甲基砷(DMA)水平,以As3+、As5+、MMA和DMA含量加和算作总砷(tAs),并计算其百分占比(As3+ %、As5+ %、MMA %、DMA %)、一甲基化率(PMI)和二甲基化率(SMI)。 结果 与对照组比较,砷中毒人群尿As3+、MMA含量和As3+ %、MMA %显著升高(P < 0.05),DMA %、PMI、SMI显著降低(P < 0.05);砷中毒皮肤损害轻、中、重度组人群尿中As3+ %明显升高(P < 0.05),DMA %、PMI、SMI明显降低(P < 0.05);砷中毒人群随皮肤损害程度加重,尿中As3+ %、MMA %逐渐升高,SMI逐渐下降(P < 0.05)。与对照组比较,砷中毒人群血清ALB和A/G明显降低(P < 0.05);随尿中As3+ %、MMA %升高和DMA %、PMI、SMI降低,ALB水平明显下降(P < 0.05);A/G随尿中As3+ %升高呈下降趋势(P < 0.05)。As3+ %、MMA %的曲线下面积(AUC)分别为0.84、0.63,两指标联合应用的AUC为0.82;As3+ %、MMA %最佳界值分别为14.37 %(特异度83.93 %,灵敏度73.27 %)、12.10 %(特异度73.21 %,灵敏度50.99 %),两指标联合应用的特异度为89.29 %,灵敏度为66.83 %。 结论 燃煤型砷中毒人群甲基化代谢能力减弱是砷致皮肤和肝脏损害的危险因素;As3+ %、MMA %可作为评估燃煤型砷中毒的潜在指标,两者联合应用可提高特异性。 Abstract:Objective To analyze the level of urinary arsenic methylation metabolism and its correlation with skin and liver damage among coal-burning arsenism patients. Methods Based on the “Diagnostic Criteria of Endemic Arsenism” (WS/T 211 — 2015) issued by Health and Family Planning Commission of the People′s Republic of China, we recruited 202 arsenism patients in an endemic area with arsenic pollution caused by coal-burning in southwestern region of Guizhou province and subdivided the patients into a mild (n = 48), moderate (n = 70) and severe group (n = 84) according to the severity of skin damage of the patients. The controls of the study were 56 healthy residents recruited in a region 12 kilometers away from the endemic arsenism area and the controls had everyday life similar to that of patients and no history of exposure to burning high arsenic coal. Serum albumin (ALB) and albumin/globulin (A/G) ratio were used to assess liver damage of the participants. High performance liquid chromatography-inductively coupled plasma mass spectrometry (HPLC-ICPMS) was adopted to detect trivalent arsenic (As3+), pentavalent arsenic (As5+), monomethyl arsenic (MMA) and dimethyl arsenic (DMA) in the urine samples of the participants and the detection results were used to calculate total arsenic (tAS), proportions of As3+, As5+, MMA and DMA (As3+%, As5+%, MMA% and DMA%), primary methylation index (PMI), and the secondary methylation index (SMI). Results Compared to the controls, the arsenism patients had significantly increased urinary As3+, MMA, As3+% and MMA% (P < 0.05 for all) but decreased DMA%, PMI and SMI (all P < 0.05). The patients′ urinary As3+% and MMA% increased and SMI decreased significantly with the severity of skin damage (P < 0.05 for all). In the arsenism patients, the serum ALB and A/G decreased significantly in comparison with those in the controls (both P < 0.05); the serum ALB declined with the increase of urinary As3+% and MMA% and the decrease of urinary DMA%, PMI and SMI (all P < 0.05), while with the increase of urinary As3+% the serum A/G declined significantly (P < 0.05). When used as two indicators for the assessment of arsenism, the urinary As3+% and MMA% presented the area under the receiver operating characteristic curve (AUC) of 0.84 and 0.63 and the optimal cutoff point of 14.37% and 12.10%; the specificity of the two cutoff points were 83.93% and 73.21% and the sensitivity of the two cutoff points were 73.27% and 50.99%. When combining As3+% and MMA% as an integrated indicator, the indicator′s AUC was 0.82, with a specificity of 89.29% and a sensitivity of 66.83%, respectively. Conclusion Attenuated arsenic methylation metabolism is a risk factor for skin and liver damage among coal-burning arsenism patients. Urinary As3+% and MMA% could be used as potential indicators for the assessment of coal-burning arsenism and the assessment specificity increases when the two indicators being combined. -
Key words:
- arsenicosis /
- coal /
- methylation metabolism /
- skin damage /
- liver damage
-
表 1 调查对象尿砷代谢指标及肝功能指标比较
组别 n 尿砷代谢指标(μg/L,M,P25~P75) 肝功能指标($ \bar x\pm s $) As3+ As5+ MMA DMA ALB(g/L) A/G 对照组 56 1.66 1.19~2.25 1.32 0.57~1.51 1.52 0.98~2.14 9.64 7.27~14.67 45.95 ± 2.86 1.56 ± 0.18 砷中毒组 202 3.58 a 2.36~5.44 1.41 0.83~2.05 2.46 a 1.30~4.17 11.68 7.24~20.00 44.48 ± 4.32 b 1.41 ± 0.56 b 注:与对照组比较,a P < 0.01,b P < 0.05。 表 2 不同程度皮肤损害组与对照组尿砷甲基化代谢指标比较( %,M,P25~P75)
组别 As3+ % As5+ % MMA % DMA % PMI SMI 对照组 11.64 7.44~13.89 7.46 4.13~11.44 10.38 6.98~12.47 69.90 65.38~80.02 81.72 75.97~87.61 86.94 84.20~92.18 砷中毒 轻度 17.08 a 12.51~20.32 7.32 3.55~12.95 10.95 8.93~13.22 63.49 a 58.51~70.57 75.89 a 69.87~80.23 84.51 b 80.99~88.16 中度 18.19 a 14.36~20.33 5.89 2.58~12.08 11.75 b 9.33~13.55 63.12 a 57.12~70.49 76.77 a 68.79~80.37 83.95 a 80.09~87.44 重度 18.57 a 14.27~21.56 6.10 3.82~13.41 13.25 a 10.19~15.99 60.51 a 52.77~65.89 73.64 a 67.61~77.80 81.31 a 78.02~86.50 注:与对照组比较,a P < 0.01,b P < 0.05。 表 3 尿砷甲基化代谢指标与皮肤损害程度回归分析
甲基化指标 B 95 % CI P 值 校正 B 95 % CI P 值 As3+ % 0.041 – 0.004~0.085 0.071 0.048 0.001~0.094 0.044 MMA % 0.110 0.036~0.185 0.004 0.104 0.027~0.182 0.008 DMA % 0.002 – 0.030~0.035 0.879 0.001 – 0.032~0.034 0.941 PMI 0.003 – 0.029~0.034 0.867 – 0.002 – 0.034~0.030 0.908 SMI – 0.050 – 0.089~ – 0.012 0.011 – 0.049 – 0.089~ – 0.008 0.019 表 4 尿砷甲基化代谢指标与肝功能指标ALB回归分析
甲基化指标 B 95 % CI P 值 校正 B 95 % CI P 值 As3+ % – 0.081 – 0.152~ – 0.010 0.025 – 0.080 – 0.152~ – 0.029 0.029 As5+ % – 0.056 – 0.118~0.007 0.080 – 0.049 – 0.111~0.013 0.123 MMA % – 0.147 – 0.253~ – 0.041 0.007 – 0.128 – 0.236~ – 0.020 0.021 DMA % 0.058 0.019~0.098 0.004 0.053 0.012~0.093 0.010 PMI 0.060 0.011~0.109 0.018 0.055 0.005~0.104 0.031 SMI 0.070 0.012~0.128 0.018 0.060 0.001~0.119 0.047 -
[1] 孙殿军, 申红梅, 高彦辉, 等. 我国重点地方病“十二五”回顾与“十三五”展望[J]. 中华地方病学杂志, 2017, 36(1): 4 – 6. doi: 10.3760/cma.j.issn.2095-4255.2017.01.002 [2] 张爱华, 姚茂琳. 贵州燃煤污染型地方性砷中毒研究进展与展望[J]. 贵州医科大学学报, 2018, 43(10): 1117 – 1123. [3] 安冬. 重视燃煤污染型地方性砷中毒的防治管理[J]. 中华地方病学杂志, 2015, 34(1): 1 – 2. doi: 10.3760/cma.j.issn.2095-4255.2015.01.001 [4] 张念恒, 李达圣, 靳争京, 等. 贵州省燃煤污染型地方性砷中毒病区综合防治后环境介质含砷量分析[J]. 中国地方病学杂志, 2013, 32(1): 30 – 32. [5] 张爱华, 曾奇兵. 新形势下地方性砷中毒科学防治的新机遇与挑战[J]. 中华地方病学杂志, 2019, 38(2): 87 – 90. doi: 10.3760/cma.j.issn.2095-4255.2019.02.001 [6] Jomova K, Jenisova Z, Feszterova M, et al. Arsenic: toxicity, oxidative stress and human disease[J]. Journal of Applied Toxicology, 2011, 31(2): 95 – 107. [7] 姚茂琳, 邹忠兰, 张爱华. 地方性砷中毒与肝损伤关系的Meta分析[J]. 中华地方病学杂志, 2019, 38(12): 1006 – 1013. doi: 10.3760/cma.j.issn.2095-4255.2019.12.016 [8] 邹忠兰, 王庆陵, 王祺, 等. 综合防控9年后贵州燃煤型砷中毒患者肝损害情况分析[J]. 贵州医科大学学报, 2018, 43(10): 1163 – 1168. [9] 中华人民共和国国家卫生和计划生育委员会. WS/T 211 — 2015: 地方性砷中毒诊断[S]. 北京: 中国标准出版社, 2015. [10] Wang DP, Luo P, Zou ZL, et al. Alterations of arsenic levels in arsenicosis residents and awareness of its risk factors: a population-based 20-year follow-up study in a unique coal-borne arsenicosis County in Guizhou, China[J]. Environment International, 2019, 129: 18 – 27. doi: 10.1016/j.envint.2019.05.005 [11] 陈保卫, 那仁满都拉, 吕美玲, 等. 砷的代谢机制、毒性和生物监测[J]. 化学进展, 2009, 21(2): 474 – 482. [12] Kligerman AD, Doerr CL, Tennant AH, et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations[J]. Environmental and Molecular Mutagenesis, 2003, 42(3): 192 – 205. doi: 10.1002/em.10192 [13] Wei BG, Yu JP, Li HR, et al. Arsenic metabolites and methylation capacity among individuals living in a rural area with endemic arseniasis in inner mongolia, China[J]. Biological Trace Element Research, 2016, 170(2): 300 – 308. doi: 10.1007/s12011-015-0490-5 [14] 郭志伟, 夏雅娟, 李艳红, 等. 饮水型砷暴露人群砷甲基化代谢水平与皮肤损伤关系的研究[J]. 中华地方病学杂志, 2020, 39(1): 38 – 41. doi: 10.3760/cma.j.issn.2095-4255.2020.01.008 [15] 张强, 郑全美, 席淑华, 等. 高砷暴露致皮肤损伤人群尿砷代谢产物分析[J]. 环境与健康杂志, 2009, 26(12): 1048 – 1050. [16] Rasheed H, Kay P, Slack R, et al. The effect of association between inefficient arsenic methylation capacity and demographic characteristics on the risk of skin lesions[J]. Toxicology and Applied Pharmacology, 2018, 339: 42 – 51. doi: 10.1016/j.taap.2017.11.026 [17] 李跃, 白广禄, 白爱梅, 等. 陕南地方性砷中毒病区人群尿中不同化学形态砷含量调查[J]. 中华地方病学杂志, 2017, 36(1): 51 – 55. doi: 10.3760/cma.j.issn.2095-4255.2017.01.012 [18] 郑奇. 检测砷中毒患者血清总蛋白、白蛋白和胆碱酯酶的意义[J]. 中国地方病防治杂志, 2014, 29(2): 145. [19] 邹忠兰, 张爱华, 杨敬源, 等. 肝生化指标在燃煤型砷中毒中诊断价值ROC曲线评价[J]. 中国公共卫生, 2016, 32(6): 861 – 865. doi: 10.11847/zgggws2016-32-06-38 [20] Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications[J]. BMC Medical Research Methodology, 2017, 17(1): 53. doi: 10.1186/s12874-017-0332-6